OMI - Owens & Minor, Inc.
NYSE
->
Healthcare
->
Medical Distribution
Mechanicsville,
United States
Type: Equity
OMI price evolution
OMI
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $243.04 | $215.19 | $286.31 | $66.84 |
| Short term investments | ||||
| Net receivables | $598.26 | $682.68 | $672.51 | $757.8 |
| Inventory | $1110.61 | $1084.35 | $1168.23 | $1288.29 |
| Total current assets | $2102.79 | $2130.27 | $2262.45 | $2268.33 |
| Long term investments | ||||
| Property, plant & equipment | $840.5 | $840.68 | $852.32 | $846.47 |
| Goodwill & intangible assets | $2000.68 | $2016.57 | $2040.17 | $2063.66 |
| Total noncurrent assets | $2990.53 | $2993.79 | $3025.55 | $3041.88 |
| Total investments | ||||
| Total assets | $5093.32 | $5124.06 | $5288 | $5310.2 |
| Current liabilities | ||||
| Accounts payable | $1171.88 | $1182.41 | $1194.17 | $1165.8 |
| Deferred revenue | ||||
| Short long term debt | $206.9 | |||
| Total current liabilities | $1891.88 | $1732.18 | $1691.64 | $1630.63 |
| Long term debt | $2113.03 | $2338.81 | $2524.76 | $2570.73 |
| Total noncurrent liabilities | $2277.27 | $2505.02 | $2700.13 | $2755.17 |
| Total debt | $2319.93 | $2338.81 | $2524.76 | $2570.73 |
| Total liabilities | $4169.16 | $4237.2 | $4391.77 | $4385.8 |
| Shareholders' equity | ||||
| Retained earnings | $368.71 | $350.92 | $357.35 | $385.59 |
| Other shareholder equity | -$31.82 | -$44.95 | -$35.99 | -$34.26 |
| Total shareholder equity | $924.17 | $886.86 | $896.23 | $924.4 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $243.04 | $69.47 | $55.71 | $83.06 |
| Short term investments | ||||
| Net receivables | $598.26 | $763.5 | $681.56 | $700.79 |
| Inventory | $1110.61 | $1333.59 | $1495.97 | $1233.75 |
| Total current assets | $2102.79 | $2295.18 | $2321.81 | $2135.86 |
| Long term investments | ||||
| Property, plant & equipment | $840.5 | $858.93 | $511.24 | $460.42 |
| Goodwill & intangible assets | $2000.68 | $2081.75 | $599.93 | $637.44 |
| Total noncurrent assets | $2990.53 | $3091.1 | $1214.74 | $1199.77 |
| Total investments | ||||
| Total assets | $5093.32 | $5386.28 | $3536.55 | $3335.64 |
| Current liabilities | ||||
| Accounts payable | $1171.88 | $1147.41 | $1001.96 | $1000.19 |
| Deferred revenue | ||||
| Short long term debt | $206.9 | |||
| Total current liabilities | $1891.88 | $1566.47 | $1344.02 | $1345.73 |
| Long term debt | $2113.03 | $2482.97 | $1109.78 | $1105.95 |
| Total noncurrent liabilities | $2277.27 | $2874.21 | $1254.03 | $1277.86 |
| Total debt | $2319.93 | $2698.44 | $1109.78 | $1105.95 |
| Total liabilities | $4169.16 | $4440.68 | $2598.05 | $2623.59 |
| Shareholders' equity | ||||
| Retained earnings | $368.71 | $410.01 | $387.62 | $167.02 |
| Other shareholder equity | -$31.82 | -$35.85 | -$40.59 | -$38.51 |
| Total shareholder equity | $924.17 | $945.6 | $938.5 | $712.05 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2656.15 | $2591.74 | $2563.23 | $2522.85 |
| Cost of revenue | $2086.23 | $2053.24 | $2043.79 | $2025.54 |
| Gross Profit | $569.92 | $538.5 | $519.43 | $497.31 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $457.23 | $452.58 | $455.03 | $448.72 |
| Total operating expenses | $509.9 | $514.66 | $508.59 | $487.5 |
| Operating income | $60.02 | $23.84 | $10.84 | $9.81 |
| Income from continuing operations | ||||
| EBIT | $57.86 | $27.14 | $9.77 | $8.42 |
| Income tax expense | $3.21 | -$4.56 | -$2.72 | -$9.36 |
| Interest expense | $36.86 | $38.13 | $40.73 | $42.2 |
| Net income | ||||
| Net income | $17.78 | -$6.43 | -$28.24 | -$24.42 |
| Income (for common shares) | $17.78 | -$6.43 | -$28.24 | -$24.42 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10333.97 | $9955.48 | $9785.32 | $8480.18 |
| Cost of revenue | $8208.81 | $8129.12 | $8272.09 | $7199.34 |
| Gross Profit | $2125.16 | $1826.35 | $1513.23 | $1280.83 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1813.56 | $1633.67 | $1116.87 | $1041.34 |
| Total operating expenses | $2020.65 | $1683.44 | $1144.76 | $1076.72 |
| Operating income | $104.51 | $142.91 | $368.47 | $204.12 |
| Income from continuing operations | ||||
| EBIT | $103.19 | $139.78 | $324.84 | $135.1 |
| Income tax expense | -$13.43 | -$11.5 | $55.16 | $21.83 |
| Interest expense | $157.91 | $128.89 | $48.09 | $83.4 |
| Net income | ||||
| Net income | -$41.3 | $22.39 | $221.59 | $29.87 |
| Income (for common shares) | -$41.3 | $22.39 | $221.59 | $29.87 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $17.78 | -$6.43 | -$28.24 | -$24.42 |
| Operating activities | ||||
| Depreciation | $70.74 | $73.65 | $72.06 | $70.93 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.8 | $5.74 | $5.21 | $6.46 |
| Total cash flows from operations | $111.77 | $157.44 | $313.11 | $158.4 |
| Investing activities | ||||
| Capital expenditures | -$38.4 | -$32.67 | -$31.07 | -$34.18 |
| Investments | ||||
| Total cash flows from investing | -$38.91 | -$32.67 | -$31.48 | -$34.18 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$50.5 | -$191.89 | -$51.8 | -$122.5 |
| Total cash flows from financing | -$51.22 | -$183 | -$55.63 | -$127.49 |
| Effect of exchange rate | $1.13 | -$0.71 | -$0.09 | $0.28 |
| Change in cash and equivalents | $22.76 | -$58.94 | $225.91 | -$2.99 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$41.3 | $22.39 | $221.59 | $29.87 |
| Operating activities | ||||
| Depreciation | $287.38 | $228.67 | $90.62 | $93.34 |
| Business acquisitions & disposals | -$1684.61 | $133 | ||
| Stock-based compensation | $23.22 | $20.99 | $25.02 | $20.01 |
| Total cash flows from operations | $740.71 | $325.01 | $124.18 | $339.22 |
| Investing activities | ||||
| Capital expenditures | -$136.32 | -$118.2 | -$49.69 | -$58.96 |
| Investments | ||||
| Total cash flows from investing | -$137.25 | -$1804.48 | -$53.63 | $80.07 |
| Financing activities | ||||
| Dividends paid | -$0.73 | -$0.65 | ||
| Sale and purchase of stock | $189.97 | |||
| Net borrowings | -$416.69 | $1582.5 | -$81.44 | -$541.85 |
| Total cash flows from financing | -$417.33 | $1497.11 | -$129.48 | -$379.39 |
| Effect of exchange rate | $0.61 | -$3.48 | -$3.54 | $9.91 |
| Change in cash and equivalents | $186.74 | $14.15 | -$62.47 | $49.82 |
News
Fundamentals
| Market cap | $1.85B |
|---|---|
| Enterprise value | $3.93B |
| Shares outstanding | 76.50M |
| Revenue | $10.33B |
|---|---|
| EBITDA | $390.57M |
| EBIT | $103.19M |
| Net Income | -$41.30M |
| Revenue Q/Q | 4.12% |
| Revenue Y/Y | 3.80% |
| P/E ratio | -44.88 |
|---|---|
| EV/Sales | 0.38 |
| EV/EBITDA | 10.06 |
| EV/EBIT | 38.09 |
| P/S ratio | 0.18 |
| P/B ratio | 1.94 |
| Book/Share | 12.50 |
| Cash/Share | 3.18 |
| EPS | -$0.54 |
|---|---|
| ROA | -0.79% |
| ROE | -4.55% |
| Debt/Equity | 4.51 |
|---|---|
| Net debt/EBITDA | 10.05 |
| Current ratio | 1.11 |
| Quick ratio | 0.52 |